Strata Critical Medical, Inc. (SRTA) key performance indicators and operating metrics (15 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 9.50 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 6.4M | FY2026-Q1 |
| Logistics Revenue | 47.6M | FY2026-Q1 |
| Free Cash Flow From Continuing Operations Before Aircraft and Engine Acquisitions | 2.1M | FY2026-Q1 |
| Gross Margin | 21.00 percent | FY2026-Q1 |
| Other Clinical Revenue | 9.95M | FY2026-Q1 |
| Transplant Clinical Revenue | 9.84M | FY2026-Q1 |
| Flight Profit | 11.6M | FY2025-Q3 |
| Flight Profit Margin | 23.60 percent | FY2025-Q3 |
| Medical Segment Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 7.6M | FY2025-Q3 |
| Medical Segment Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 15.30 percent | FY2025-Q3 |
| Medical Revenue | 45.1M | FY2025-Q2 |
| Jet and Other Revenue | 8.5M | FY2025-Q2 |
| Short Distance Revenue | 17.2M | FY2025-Q2 |
Back to SRTA overview · SRTA earnings · SRTA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.